Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer

Breast cancer is characterized by a high incidence rate and its treatment challenges, particularly in certain subtypes. Consequently, there is an urgent need for the development of novel therapeutic approaches. Immunotherapy utilizing immune checkpoint inhibitors (ICIs) is currently gaining momentum...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongsheng, Mi, Jintao, Xin, Qi, Cao, Weiwei, Song, Chunjiao, Zhang, Naidan, Yuan, Chengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582933/
https://www.ncbi.nlm.nih.gov/pubmed/37860188
http://dx.doi.org/10.3389/fonc.2023.1256360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582933/
https://www.ncbi.nlm.nih.gov/pubmed/37860188
http://dx.doi.org/10.3389/fonc.2023.1256360

Ejemplares similares